{"database": "lobbying", "table": "lobbying_activities", "rows": [[1440896, "f8d30612-a0f7-43ef-998a-4c4cfbd192aa", "Q3", "STANTON PARK GROUP", 83717, "ALKERMES, INC.", 2013, "third_quarter", "PHA", "increasing acceptance of medication assisted therapy in treating abuse of alcohol and opioid dependence", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2013-10-11T12:46:37.847000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1440896"], "units": {}, "query_ms": 15.500554989557713, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}